Deputy Director, Centre for the AIDS Program of Research in South Africa (CAPRISA)
Dr Nesri Padayatchi, MBChB, DCH(Paediatrics), DTM&H (Tropical Medicine), DPH(Public Health), DHSM (Health Management) MS(Epi), is currently the Deputy Director of CAPRISA and an honorary Associate Professor in Public Health and Nursing, in the College of Health Sciences at the University of KwaZulu-Natal in Durban, South Africa.
Her clinical and research experience in the management of TB and related problems spans over 30 years, nationally and globally. She serves on the board of the Southern African HIV Clinicians Society and is an advisor on India’s TB Research Consortium. Dr Padayatchi is an Independent Data Monitoring Committee member of the British MRC ‘s STREAM study. She serves as an advisor on the Ethics Advisory Group of the International Union against TB and Lung Diseases; and is a member of the Academy of Science of South Africa.
Dr Padayatchi has made significant scientific contributions as a co-investigator in the SAPiT and STRIDE (A5221) studies on the management of patients with TB-HIV coinfection, which shaped the World Heath Organisation, the South African and United States Department of Health & Human Services guidelines. She was awarded the South African Medical Research Council Scientific Merit award (silver) for her scientific contributions. She has published widely in the field of TB-HIV in peer reviewed journals and serves as a reviewer for many international and local journals.
She served as the South African Principal Investigator for the Columbia University-Southern African Fogarty AIDS International Training and Research Programme and on several boards including the South African National and Provincial Advisory Boards for MDR –TB. Dr Padayatchi has participated as the Principal investigator in the Centres for Disease Control and Prevention TB Trials Consortium, as well as the ACTG network studies.
Jul 21, 2020 14:02 pm UTC| Health
When the COVID-19 pandemic began to spread rapidly across the globe, scientists expressed concern that people living with HIV would be particularly severely affected. This was because those with compromised immune systems...